First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Clinical trial NCT05427253 · COMPLETED

Trial details

NCT number: NCT05427253
Sponsor: Vicore Pharma AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Issues Tolerance Idiopathic Pulmonary Fibrosis Pulmonary Hypertension

Start date: 2022-06-08
Primary completion: 2023-06-22
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.